TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Roche Products
Curated by ChEMBL
Roche Products
Curated by ChEMBL
Affinity DataKi: 0.120nMAssay Description:Binding activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Roche Products
Curated by ChEMBL
Roche Products
Curated by ChEMBL
Affinity DataKi: 0.120nMAssay Description:The compound was tested for binding activity against HIV-1 proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Roche Products
Curated by ChEMBL
Roche Products
Curated by ChEMBL
Affinity DataKi: 0.240nMAssay Description:Binding activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Roche Products
Curated by ChEMBL
Roche Products
Curated by ChEMBL
Affinity DataKi: 0.240nMAssay Description:The compound was tested for binding activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Roche Products
Curated by ChEMBL
Roche Products
Curated by ChEMBL
Affinity DataKi: 0.600nMAssay Description:The compound was tested for binding activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Roche Products
Curated by ChEMBL
Roche Products
Curated by ChEMBL
Affinity DataKi: 0.600nMAssay Description:Binding activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Roche Products
Curated by ChEMBL
Roche Products
Curated by ChEMBL
Affinity DataIC50: <0.400nMAssay Description:Binding activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Roche Products
Curated by ChEMBL
Roche Products
Curated by ChEMBL
Affinity DataIC50: <0.400nMAssay Description:Binding activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Roche Products
Curated by ChEMBL
Roche Products
Curated by ChEMBL
Affinity DataIC50: <2.70nMAssay Description:Binding activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Roche Products
Curated by ChEMBL
Roche Products
Curated by ChEMBL
Affinity DataIC50: <2.70nMAssay Description:Binding activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Roche Products
Curated by ChEMBL
Roche Products
Curated by ChEMBL
Affinity DataIC50: 13nMAssay Description:Binding activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Roche Products
Curated by ChEMBL
Roche Products
Curated by ChEMBL
Affinity DataIC50: 13nMAssay Description:Binding activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Roche Products
Curated by ChEMBL
Roche Products
Curated by ChEMBL
Affinity DataIC50: >100nMAssay Description:Binding activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Roche Products
Curated by ChEMBL
Roche Products
Curated by ChEMBL
Affinity DataIC50: >100nMAssay Description:Binding activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Roche Products
Curated by ChEMBL
Roche Products
Curated by ChEMBL
Affinity DataIC50: >100nMAssay Description:Binding activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Roche Products
Curated by ChEMBL
Roche Products
Curated by ChEMBL
Affinity DataIC50: >100nMAssay Description:Binding activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Roche Products
Curated by ChEMBL
Roche Products
Curated by ChEMBL
Affinity DataIC50: >100nMAssay Description:Binding activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Roche Products
Curated by ChEMBL
Roche Products
Curated by ChEMBL
Affinity DataIC50: >100nMAssay Description:Binding activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Roche Products
Curated by ChEMBL
Roche Products
Curated by ChEMBL
Affinity DataIC50: >100nMAssay Description:Binding activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Roche Products
Curated by ChEMBL
Roche Products
Curated by ChEMBL
Affinity DataIC50: >100nMAssay Description:Binding activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Roche Products
Curated by ChEMBL
Roche Products
Curated by ChEMBL
Affinity DataIC50: >100nMAssay Description:Binding activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Ariad Pharmaceuticals
Curated by ChEMBL
Ariad Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 100nMAssay Description:Binding affinity against Src SH2 domain in competitive fluorescence polarization assayMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Roche Products
Curated by ChEMBL
Roche Products
Curated by ChEMBL
Affinity DataIC50: 140nMAssay Description:Binding activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Roche Products
Curated by ChEMBL
Roche Products
Curated by ChEMBL
Affinity DataIC50: 140nMAssay Description:The compound was tested for binding activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Ariad Pharmaceuticals
Curated by ChEMBL
Ariad Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:Binding affinity against Src SH2 domain in competitive fluorescence polarization assayMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Roche Products
Curated by ChEMBL
Roche Products
Curated by ChEMBL
Affinity DataIC50: 300nMAssay Description:Binding activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Roche Products
Curated by ChEMBL
Roche Products
Curated by ChEMBL
Affinity DataIC50: 300nMAssay Description:Binding activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Ariad Pharmaceuticals
Curated by ChEMBL
Ariad Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 350nMAssay Description:Inhibition of binding to Src SH2 domainMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Roche Products
Curated by ChEMBL
Roche Products
Curated by ChEMBL
Affinity DataIC50: 420nMAssay Description:Binding activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Roche Products
Curated by ChEMBL
Roche Products
Curated by ChEMBL
Affinity DataIC50: 420nMAssay Description:Binding activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Ariad Pharmaceuticals
Curated by ChEMBL
Ariad Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.60E+3nMAssay Description:Binding affinity against Src SH2 domain in competitive fluorescence polarization assayMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Ariad Pharmaceuticals
Curated by ChEMBL
Ariad Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.00E+3nMAssay Description:Binding affinity against Src SH2 domain in competitive fluorescence polarization assayMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Ariad Pharmaceuticals
Curated by ChEMBL
Ariad Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.20E+3nMAssay Description:Inhibition of binding to Src SH2 domainMore data for this Ligand-Target Pair
Affinity DataIC50: 2.60E+3nMAssay Description:Inhibition of binding to Yes SH2 domainMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Ariad Pharmaceuticals
Curated by ChEMBL
Ariad Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.70E+3nMAssay Description:Inhibition of binding to Src SH2 domainMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Ariad Pharmaceuticals
Curated by ChEMBL
Ariad Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3.20E+3nMAssay Description:Inhibition of binding to Src SH2 domainMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Ariad Pharmaceuticals
Curated by ChEMBL
Ariad Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3.60E+3nMAssay Description:Inhibition of binding to Src SH2 domainMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Ariad Pharmaceuticals
Curated by ChEMBL
Ariad Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of binding to Src SH2 domainMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Ariad Pharmaceuticals
Curated by ChEMBL
Ariad Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 5.60E+3nMAssay Description:Binding affinity against Src SH2 domain in competitive fluorescence polarization assayMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Ariad Pharmaceuticals
Curated by ChEMBL
Ariad Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 6.00E+3nMAssay Description:Inhibition of binding to Src SH2 domainMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Ariad Pharmaceuticals
Curated by ChEMBL
Ariad Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 7.30E+3nMAssay Description:Inhibition of binding to Src SH2 domainMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Ariad Pharmaceuticals
Curated by ChEMBL
Ariad Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 7.90E+3nMAssay Description:Inhibition of binding to Src SH2 domainMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Ariad Pharmaceuticals
Curated by ChEMBL
Ariad Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 8.10E+3nMAssay Description:Binding affinity against Src SH2 domain in competitive fluorescence polarization assayMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Ariad Pharmaceuticals
Curated by ChEMBL
Ariad Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.60E+4nMAssay Description:Inhibition of binding to Src SH2 domainMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Ariad Pharmaceuticals
Curated by ChEMBL
Ariad Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3.20E+4nMAssay Description:Binding affinity against Src SH2 domain in competitive fluorescence polarization assayMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Ariad Pharmaceuticals
Curated by ChEMBL
Ariad Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3.54E+4nMAssay Description:Inhibition of binding to Src SH2 domainMore data for this Ligand-Target Pair
Affinity DataIC50: 9.45E+4nMAssay Description:Inhibition of binding to Yes SH2 domainMore data for this Ligand-Target Pair
Affinity DataIC50: 1.10E+5nMAssay Description:Inhibition of binding to Yes SH2 domainMore data for this Ligand-Target Pair
Affinity DataIC50: 1.56E+5nMAssay Description:Inhibition of binding to Yes SH2 domainMore data for this Ligand-Target Pair
Affinity DataIC50: 3.03E+5nMAssay Description:Inhibition of binding to Yes SH2 domainMore data for this Ligand-Target Pair